Article Figures & Tables
Figures
- Figure 1
Age- and sex-standardized prevalance of dementia among community-dwelling patients aged 65 years and older, by year and province (for supporting data, see Appendix 1, available at www.cmajopen.ca/content/4/2/E177/suppl/DC1).
Tables
Age group, yr Sex; % of patients (n/N) [95% CI] Male Female 65-74 2.4 (336/13 964) [2.2-2.7] 2.5 (426/16 914) [2.3-2.8] 75-84 9.0 (745/8 243) [8.4-9.7] 9.7 (1 067/10 978) [9.2-10.3] ≥ 85 20.5 (648/3 158) [8.4-9.7] 22.5 (1 330/5 920) [21.4-23.5] Total (observed) 7.7 (4 552/59 177) [7.5-7.9] Total (age and sex standardized) 7.3 [7.1-7.5] Note: CI = confidence interval.
Factor No. of patients Prevalence ratio
(95% CI)Residence location Urban 42 940 1.00 (ref) Rural 14 438 0.93 (0.87-1.00) Missing data 1 799 1.50 (1.36-1.67) Weight category (BMI) Normal (18-24) 12 246 1.00 (ref) Underweight (< 18) 1 552 1.13 (0.98-1.33) Overweight (25-29) 14 510 0.94 (0.87-1.03) Obese (≥ 30) 12 843 0.89 (0.81-0.97) Missing data 18 026 1.03 (0.96-1.11) Comorbidity Hypertension 30 691 0.97 (0.95-1.00) Diabetes 13 130 1.10 (1.04-1.16) Depression 9 355 2.40 (2.29-2.52) COPD 6 704 1.08 (1.00-1.17) Osteoarthritis 17 028 1.01 (0.97-1.06) Epilepsy 592 2.89 (2.32-3.60) Parkinsonism 794 2.93 (2.47-3.47) Note: BMI = body mass index, CI = confidence interval, COPD = chronic obstructive pulmonary disorder, ref = reference group.
- Table 3: Number and type of dementia medications prescribed by primary care providers to patients with dementia, by year and province Table 3: Number and type of dementia medications prescribed by primary care providers to patients with dementia, by year and province
Variable Year; no. (%) of patients 2008 2009 2010 2011 2012 Alberta No. of medications* 0 658 (94.8) 632 (91.1) 616 (88.6) 616 (88.8) 609 (87.8) 1 33 (4.8) 60 (8.7) 77 (11.1) 75 (10.8) 85 (12.3) 2 3 (0.4) 2 (0.3) 1 (0.1) 3 (0.4) 0 3-4 0 0 1 (0.1) 0 0 Type of medication† Donepezil 21 (60.0) 21 (65.6) 28 (62.2) 29 (72.5) 57 (67.1) Galantamine 13 (37.1) 7 (21.9) 17 (37.8) 12 (30.0) 24 (28.2) Memantine 4 (11.4) 2 (6.3) 1 (2.2) 1 (2.5) 7 (8.2) Rivastigmine 4 (11.4) 4 (12.5) 3 (6.7) 7 (17.5) 9 (10.6) Manitoba No. of medications* 0 466 (94.1) 456 (92.1) 446 (90.1) 445 (89.9) 445 (89.0) 1 28 (5.7) 38 (7.7) 48 (9.7) 49 (9.9) 49 (9.9) 2 1 (0.2) 1 (0.2) 1 (0.2) 1 (0.2) 1 (0.2) 3-4 0 0 0 1 (0.2) 0 Type of medication† Donepezil 11 (91.7) 11 (84.6) 14 (82.4) 17 (77.3) 47 (94.0) Galantamine 1 (8.3) 4 (30.8) 2 (11.8) 7 (31.8) 4 (8.0) Memantine 0 0 0 0 1 (2.0) Rivastigmine 1 (8.3) 0 1 (5.9) 1 (4.6) 3 (6.0) Newfoundland and Labrador No. of medications* 0 271 (92.8) 253 (86.6) 227 (77.7) 207 (70.9) 207 (70.9) 1 20 (6.9) 34 (11.6) 62 (21.2) 83 (28.4) 83 (28.4) 2 0 4 (1.4) 3 (1.0) 1 (0.3) 2 (0.7) 3-4 1 (0.3) 1 (0.3) 0 1 (0.3) 0 Type of medication† Donepezil 6 (66.7) 7 (77.8) 16 (64.0) 29 (65.9) 75 (88.2) Galantamine 3 (33.3) 2 (22.2) 9 (36.0) 22 (50.0) 16 (18.8) Memantine 1 (11.1) 1 (11.1) 5 (20.0) 1 (2.3) 0 Rivastigmine 2 (22.2) 0 1 (4.0) 2 (4.6) 1 (1.2) Nova Scotia No. of medications* 0 491 (89.9) 468 (85.7) 429 (78.6) 383 (70.2) 397 (72.7) 1 51 (9.3) 73 (13.4) 110 (20.2) 154 (28.2) 139 (25.5) 2 4 (0.7) 5 (0.9) 7 (1.3) 8 (1.5) 10 (1.8) 3-4 0 0 0 1 (0.2) 0 Type of medication† Donepezil 7 (53.9) 2 (18.2) 14 (53.9) 38 (56.7) 90 (60.4) Galantamine 4 (30.8) 9 (81.8) 16 (61.5) 29 (43.3) 62 (41.6) Memantine 1 (7.7) 0 1 (3.9) 3 (4.5) 8 (5.4) Rivastigmine 1 (7.7) 0 2 (7.7) 7 (10.5) 17 (11.4) Ontario No. of medications* 0 1934 (92.8) 1812 (86.9) 1678 (80.5) 1589 (76.2) 1557 (74.7) 1 135 (6.5) 248 (11.9) 357 (17.1) 432 (20.7) 459 (22.0) 2 14 (0.7) 23 (1.1) 49 (2.4) 62 (3.0) 66 (3.2) 3-4 2 (0.1) 2 (0.1) 1 (0.1) 2 (0.1) 3 (0.1) Type of medication† Donepezil 25 (67.6) 30 (63.8) 68 (58.6) 138 (60.3) 343 (62.9) Galantamine 8 (21.6) 18 (38.3) 49 (42.2) 81 (35.4) 191 (35.1) Memantine 4 (10.8) 5 (10.6) 15 (12.9) 45 (19.7) 95 (17.4) Rivastigmine 3 (8.1) 7 (14.9) 12 (10.3) 27 (11.8) 59 (10.8) *Dementia medications are donepezil, galantamine, memantine and rivastigmine.
†Totals may exceed 100% because some patients were prescribed more than 1 medication.
In this issue
Article tools
Respond to this article
Related Articles
Cited By...
- No citing articles found.